The effect of α-adrenergic antagonists in chronic prostatitis/chronic pelvic pain syndrome:: A meta-analysis of randomized controlled trials

被引:17
作者
Yang, Gang [1 ]
Wei, Qiang [1 ]
Li, Hong [1 ]
Yang, Yuru [1 ]
Zhang, Sixiao [1 ]
Dong, Qiang [1 ]
机构
[1] Sichuan Univ, Dept Urol, W China Hosp, Chengdu 610041, Peoples R China
来源
JOURNAL OF ANDROLOGY | 2006年 / 27卷 / 06期
关键词
evidence-based medicine; prostate; drug treatment; BENIGN PROSTATIC HYPERPLASIA; DOUBLE-BLIND TRIAL; THERAPY; MEN; TAMSULOSIN;
D O I
10.2164/jandrol.106.000661
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
The effectiveness of a-adrenergic antagonists on patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) has not been supported by well-evaluated study. The metaanalysis was performed to supply the best evidence about use of this class of drugs in CP/CPPS. A fully recursive literature search to June 2005 was conducted in PubMed, EMBASE, the Cochrane Controlled Trials Register, and the Chinese Biomedicine Database to identify potentially relevant randomized controlled trials. RevMan4.2 was used for statistical analysis. Nine studies with 734 patients were included. Combined analysis showed a significant reduction of total NIH-CPSI or I-PSS in patients with treatment duration of more than 3 months. There were also valuable results in urinary symptom alleviation. Alpha-adrenergic antagonists did not show benefit in pain. The meta-analysis revealed that the use of a-adrenergic antagonists was warranted in CP/CPPS, and the treatment duration should be long enough (more than 3 months).
引用
收藏
页码:847 / 852
页数:6
相关论文
共 21 条
[1]   Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome - A randomized, double-blind trial [J].
Alexander, RB ;
Propert, KJ ;
Schaeffer, AJ ;
Landis, JR ;
Nickel, JC ;
O'Leary, MP ;
Pontari, MA ;
McNaughton-Collins, M ;
Shoskes, DA ;
Comiter, CV ;
Datta, NS ;
Fowler, JE ;
Nadler, RB ;
Zeitlin, SI ;
Knauss, JS ;
Wang, YL ;
Kusek, JW ;
Nyberg, LM ;
Litwin, MS .
ANNALS OF INTERNAL MEDICINE, 2004, 141 (08) :581-589
[2]   Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: A randomized, placebo controlled trial [J].
Cheah, PY ;
Liong, ML ;
Yuen, KH ;
Teh, CL ;
Khor, T ;
Yang, JR ;
Yap, HW ;
Krieger, JN .
JOURNAL OF UROLOGY, 2003, 169 (02) :592-596
[3]   Diagnosis and treatment of chronic abacterial prostatitis: A systematic review [J].
Collins, MM ;
MacDonald, R ;
Wilt, TJ .
ANNALS OF INTERNAL MEDICINE, 2000, 133 (05) :367-381
[4]   Epidemiologic association between prostatitis and prostate cancer [J].
Dennis, LK ;
Lynch, CF ;
Torner, JC .
UROLOGY, 2002, 60 (01) :78-83
[5]   Chronic prostatitis/chronic pelvic pain syndrome: Is there a role for local drug infiltration therapy? [J].
El-Hakim, A .
JOURNAL OF ENDOUROLOGY, 2004, 18 (03) :227-231
[6]   Lower urinary tract symptoms, pain and quality of life assessment in chronic non-bacterial prostatitis patients treated with α-blocking agent doxazosin; Versus placebo [J].
Evliyaoǧlu Y. ;
Burgut R. .
International Urology and Nephrology, 2002, 34 (3) :351-356
[7]   Use of terazosine in patients with chronic pelvic pain syndrome and evaluation by prostatitis symptom score index [J].
Gül O. ;
Eroğlu M. ;
Özok U. .
International Urology and Nephrology, 2001, 32 (3) :433-436
[8]   Acute and chronic prostatitis [J].
Hua, VN ;
Schaeffer, AJ .
MEDICAL CLINICS OF NORTH AMERICA, 2004, 88 (02) :483-+
[9]  
KREIGER JN, 2004, MINERVA UROL NEFROL, V56, P99
[10]   NIH consensus definition and classification of prostatitis [J].
Krieger, JN ;
Nyberg, L ;
Nickel, JC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (03) :236-237